These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1616890

  • 1. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC).
    Di Costanzo F, Bartolucci R, Calabresi F, Sofra M, Marzola M, Belsanti V, Boni C, Bacchi M.
    Ann Oncol; 1992 May; 3(5):371-6. PubMed ID: 1616890
    [Abstract] [Full Text] [Related]

  • 2. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A.
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [Abstract] [Full Text] [Related]

  • 3. Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
    Köhne CH, Wilke H, Hecker H, Schöffski P, Käufer C, Rauschecker H, Andreesen R, Ohl U, Lange HJ, Klaassen U.
    Ann Oncol; 1995 May; 6(5):461-6. PubMed ID: 7669711
    [Abstract] [Full Text] [Related]

  • 4. High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
    Di Costanzo F, Gasperoni S, Malacarne P, Belsanti V, Luppi G, Marzola M, Corgna E, Sdrobolini A, Passalacqua R, Figoli F, Algeri R, Zironi S, Angiona S, Boni C.
    Am J Clin Oncol; 1998 Aug; 21(4):369-75. PubMed ID: 9708636
    [Abstract] [Full Text] [Related]

  • 5. Fluorouracil and leucovorin for metastatic colorectal cancer.
    Erlichman C.
    J Chemother; 1990 Feb; 2 Suppl 1():38-40. PubMed ID: 2195136
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
    Ducreux M, Van Cutsem E, Van Laethem JL, Gress TM, Jeziorski K, Rougier P, Wagener T, Anak O, Baron B, Nordlinger B, EORTC Gastro Intestinal Tract Cancer Group.
    Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
    Machiavelli M, Leone BA, Romero A, Rabinovich MG, Vallejo CT, Bianco A, Pérez JE, Rodríguez R, Cuevas MA, Alvarez LA.
    Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
    [Abstract] [Full Text] [Related]

  • 10. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW.
    J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
    [Abstract] [Full Text] [Related]

  • 11. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
    Buroker TR, O'Connell MJ, Wieand HS, Krook JE, Gerstner JB, Mailliard JA, Schaefer PL, Levitt R, Kardinal CG, Gesme DH.
    J Clin Oncol; 1994 Jan; 12(1):14-20. PubMed ID: 7677801
    [Abstract] [Full Text] [Related]

  • 12. Randomized trial of 5-fluorouracil and high-dose folinic acid with or without alpha-2B interferon in advanced colorectal cancer.
    Recchia F, Nuzzo A, Lalli A, Lombardo M, Di Lullo L, Fabiani F, Fanini R, Venturoni L, Torchio P, Peretti G.
    Am J Clin Oncol; 1996 Jun; 19(3):301-4. PubMed ID: 8638546
    [Abstract] [Full Text] [Related]

  • 13. Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer.
    Labianca R, Giaccon G, Barni S, Ambrosini G, Iirillo A, Fiorentini G, Duro M, Piazza E, Oliani C, Pancera G.
    Eur J Cancer; 1994 Jun; 30A(11):1611-6. PubMed ID: 7833131
    [Abstract] [Full Text] [Related]

  • 14. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
    Carlomagno C, Lauria R, De Laurentiis M, Arpino G, Massarelli E, Ferrara C, Milano A, Vernaglia Lombardi A, Costanzo R, Catalano G, Bianco AR, De Placido S.
    Oncology; 2002 Jun; 63(3):219-25. PubMed ID: 12381900
    [Abstract] [Full Text] [Related]

  • 15. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    Köhne CH, Wils J, Lorenz M, Schöffski P, Voigtmann R, Bokemeyer C, Lutz M, Kleeberg C, Ridwelski K, Souchon R, El-Serafi M, Weiss U, Burkhard O, Rückle H, Lichnitser M, Langenbuch T, Scheithauer W, Baron B, Couvreur ML, Schmoll HJ, European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    J Clin Oncol; 2003 Oct 15; 21(20):3721-8. PubMed ID: 12963704
    [Abstract] [Full Text] [Related]

  • 16. Treatment of advanced colorectal cancer with high-dose intensity folinic acid and 5-fluorouracil plus supportive care.
    Petrioli R, Lorenzi M, Aquino A, Marsili S, Frediani B, Palazzuoli V, Marzocca G, Botta G, Tani F, De Martino A.
    Eur J Cancer; 1995 Nov 15; 31A(12):2105-8. PubMed ID: 8562173
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma.
    Gennatas C, Papaxoinis G, Michalaki V, Mouratidou D, Andreadis C, Tsavaris N, Pafiti A.
    J Chemother; 2006 Oct 15; 18(5):538-44. PubMed ID: 17127232
    [Abstract] [Full Text] [Related]

  • 18. 5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
    Tsavaris NB, Tentas K, Kosmidis P, Mylonakis N, Sakelaropoulos N, Kosmas C, Lisaios B, Soumilas A, Mandrekois D, Tsetis A, Klonaris C.
    Am J Clin Oncol; 1996 Oct 15; 19(5):517-21. PubMed ID: 8823483
    [Abstract] [Full Text] [Related]

  • 19. Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
    Abad A, Garcia P, Gravalos C, Tusquets I, Font A, Perez G, Cortés-Funes H, Fabregat X, Barnadas A, Rosell R.
    Cancer; 1995 Mar 15; 75(6):1238-44. PubMed ID: 7882275
    [Abstract] [Full Text] [Related]

  • 20. 5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group.
    Maiello E, Gebbia V, Giuliani F, Paoletti G, Gebbia N, Cigolari S, Fortunato S, Pedicini T, Borsellino N, Lopez M, Colucci G.
    Ann Oncol; 2000 Aug 15; 11(8):1045-51. PubMed ID: 11038044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.